FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018213809> ?p ?o ?g. }

• W2018213809 endingPage "221" @default.
• W2018213809 startingPage "221" @default.
• W2018213809 abstract "Purpose: Topical calcineurin inhibitor is recently developed topical immunomodulator, and preliminary studies showed its effectiveness in the treatment of atopic dermatitis (AD). However, some side effects including transient irritation can influence the patient compliance. So, there are some needs to improve the patient compliance. The purpose of this study was to evaluate the efficacy, safety and patient compliance with using topical tacrolimus 0.1% to treat AD when the correct information about topical tacrolimus are properly given to patients. Methods: We examined the medical recordings, clinical severity scoring of total 194 AD patients at 9 general hospitals in Seoul, Korea from September 2010 to August 2011. We offered an infosheet of topical tacrolimus 0.1% and the patients applied it twice a day for 2 weeks. And we measured the efficacy of the topical tacrolimus 0.1% with SCORing atopic dermatitis (SCORAD) index, patient`s global assessment (PGA), and investigator`s global assessment (IGA). Results: Topical tacrolimus 0.1% effectively controlled AD with a reduction of the SCORAD index from baseline 31.9 to 20.2 at 2 weeks of application. In IGA results showed 98% got improvement and in PGA, results showed 96% got improvement after treatment. Although 42.3% of the patients complained of adverse effects, these were all transient. The effect of information on topical tacrolimus 0.1% showed 34% patients could predict the side effect, 35% patients could feel safety to use, and 18% patients experienced side effect but could maintain topical calcineurin inhibitor. Conclusion: Topical tacrolimus 0.1% may be an effective treatment modality for AD when patients show good compliance for applying the ointment. And properly given, the correct information may increase the patient compliance. (Allergy Asthma Respir Dis 2013;1:221-226)" @default.
• W2018213809 created "2016-06-24" @default.
• W2018213809 creator A5015033974 @default.
• W2018213809 creator A5017971293 @default.
• W2018213809 creator A5020627389 @default.
• W2018213809 creator A5021865337 @default.
• W2018213809 creator A5023399579 @default.
• W2018213809 creator A5033606569 @default.
• W2018213809 creator A5036418211 @default.
• W2018213809 creator A5045708937 @default.
• W2018213809 creator A5046399590 @default.
• W2018213809 creator A5057564592 @default.
• W2018213809 creator A5057582488 @default.
• W2018213809 creator A5058930201 @default.
• W2018213809 creator A5066925488 @default.
• W2018213809 creator A5070738695 @default.
• W2018213809 creator A5074378009 @default.
• W2018213809 creator A5075658511 @default.
• W2018213809 creator A5079910860 @default.
• W2018213809 creator A5087957705 @default.
• W2018213809 date "2013-01-01" @default.
• W2018213809 modified "2023-10-16" @default.
• W2018213809 title "Effect of infosheet for topical tacrolimus 0.1% and its efficacy and compliance in the treatment of atopic dermatitis" @default.
• W2018213809 cites W1574593504 @default.
• W2018213809 cites W1984760134 @default.
• W2018213809 cites W1990375874 @default.
• W2018213809 cites W1991975354 @default.
• W2018213809 cites W2014280584 @default.
• W2018213809 cites W2020449577 @default.
• W2018213809 cites W2020739778 @default.
• W2018213809 cites W2047914099 @default.
• W2018213809 cites W2067510223 @default.
• W2018213809 cites W2099773744 @default.
• W2018213809 cites W2142040104 @default.
• W2018213809 cites W2143138262 @default.
• W2018213809 cites W2156488305 @default.
• W2018213809 cites W2161109778 @default.
• W2018213809 cites W2248650788 @default.
• W2018213809 cites W2325223138 @default.
• W2018213809 cites W2329826355 @default.
• W2018213809 cites W4242340781 @default.
• W2018213809 cites W4248663145 @default.
• W2018213809 doi "https://doi.org/10.4168/aard.2013.1.3.221" @default.
• W2018213809 hasPublicationYear "2013" @default.
• W2018213809 type Work @default.
• W2018213809 sameAs 2018213809 @default.
• W2018213809 citedByCount "0" @default.
• W2018213809 crossrefType "journal-article" @default.
• W2018213809 hasAuthorship W2018213809A5015033974 @default.
• W2018213809 hasAuthorship W2018213809A5017971293 @default.
• W2018213809 hasAuthorship W2018213809A5020627389 @default.
• W2018213809 hasAuthorship W2018213809A5021865337 @default.
• W2018213809 hasAuthorship W2018213809A5023399579 @default.
• W2018213809 hasAuthorship W2018213809A5033606569 @default.
• W2018213809 hasAuthorship W2018213809A5036418211 @default.
• W2018213809 hasAuthorship W2018213809A5045708937 @default.
• W2018213809 hasAuthorship W2018213809A5046399590 @default.
• W2018213809 hasAuthorship W2018213809A5057564592 @default.
• W2018213809 hasAuthorship W2018213809A5057582488 @default.
• W2018213809 hasAuthorship W2018213809A5058930201 @default.
• W2018213809 hasAuthorship W2018213809A5066925488 @default.
• W2018213809 hasAuthorship W2018213809A5070738695 @default.
• W2018213809 hasAuthorship W2018213809A5074378009 @default.
• W2018213809 hasAuthorship W2018213809A5075658511 @default.
• W2018213809 hasAuthorship W2018213809A5079910860 @default.
• W2018213809 hasAuthorship W2018213809A5087957705 @default.
• W2018213809 hasConcept C126322002 @default.
• W2018213809 hasConcept C15744967 @default.
• W2018213809 hasConcept C16005928 @default.
• W2018213809 hasConcept C2778329239 @default.
• W2018213809 hasConcept C2781460075 @default.
• W2018213809 hasConcept C2909675724 @default.
• W2018213809 hasConcept C2911091166 @default.
• W2018213809 hasConcept C71924100 @default.
• W2018213809 hasConcept C77805123 @default.
• W2018213809 hasConceptScore W2018213809C126322002 @default.
• W2018213809 hasConceptScore W2018213809C15744967 @default.
• W2018213809 hasConceptScore W2018213809C16005928 @default.
• W2018213809 hasConceptScore W2018213809C2778329239 @default.
• W2018213809 hasConceptScore W2018213809C2781460075 @default.
• W2018213809 hasConceptScore W2018213809C2909675724 @default.
• W2018213809 hasConceptScore W2018213809C2911091166 @default.
• W2018213809 hasConceptScore W2018213809C71924100 @default.
• W2018213809 hasConceptScore W2018213809C77805123 @default.
• W2018213809 hasIssue "3" @default.
• W2018213809 hasLocation W20182138091 @default.
• W2018213809 hasOpenAccess W2018213809 @default.
• W2018213809 hasPrimaryLocation W20182138091 @default.
• W2018213809 hasRelatedWork W156382480 @default.
• W2018213809 hasRelatedWork W2080412111 @default.
• W2018213809 hasRelatedWork W2146668877 @default.
• W2018213809 hasRelatedWork W2336509786 @default.
• W2018213809 hasRelatedWork W2437395753 @default.
• W2018213809 hasRelatedWork W2604148998 @default.
• W2018213809 hasRelatedWork W3115042814 @default.
• W2018213809 hasRelatedWork W3180217476 @default.
• W2018213809 hasRelatedWork W404141560 @default.
• W2018213809 hasRelatedWork W2527430682 @default.

• next